-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Oric Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q3 2024.
- Oric Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$38.3M, a 33.6% decline year-over-year.
- Oric Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$135M, a 32.8% decline year-over-year.
- Oric Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$111M, a 20.7% decline from 2022.
- Oric Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$91.8M, a 16.4% decline from 2021.
- Oric Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$78.9M, a 6.32% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)